Pharvaris N.V. - Ordinary Shares, par value Euro 0.12 per share (PHVS)

CUSIP: N69605108

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class
Equity / Ordinary Shares, par value Euro 0.12 per share
Shares outstanding
65,237,679
Total 13F shares
21,995,815
Share change
-29,307
Total reported value
$406,288,000
Price per share
$18.62
Number of holders
28
Value change
-$1,442,853
Number of buys
11
Number of sells
13

Security key

N69605108

Report period

Q2 2021

Institutions

28

Top holders

10

Top shareholders of PHVS - Pharvaris N.V. - Ordinary Shares, par value Euro 0.12 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Foresite Capital Management IV, LLC
13F
Company
5%
3,261,926
$91,269,000 31 Mar 2021
13F
Bain Capital Life Sciences Investors, LLC
13F
Company
4.9%
3,180,601
$88,993,000 31 Mar 2021
13F
FMR LLC
13F
Company
4.2%
2,767,727
$77,663,000 31 Mar 2021
13F
VIKING GLOBAL INVESTORS LP
13F
Company
3.7%
2,420,155
$67,910,000 31 Mar 2021
13F
GENERAL ATLANTIC, L.P.
13F
Company
3.7%
2,420,155
$67,716,000 31 Mar 2021
13F
venBio Partners LLC
13F
Company
3.5%
2,303,310
$64,447,000 31 Mar 2021
13F
DEERFIELD MANAGEMENT COMPANY, L.P.
13F
Company
1.6%
1,032,757
$28,897,000 31 Mar 2021
13F
Venrock Adviser, LLC
13F
Company
1.4%
902,882
$25,335,000 31 Mar 2021
13F
Cormorant Asset Management, LP
13F
Company
1.3%
864,143
$23,811,000 31 Mar 2021
13F
Foresite Capital Management V, LLC
13F
Company
1%
664,142
$18,583,000 31 Mar 2021
13F
PICTET ASSET MANAGEMENT LTD
13F
Company
0.85%
553,185
$15,522,000 31 Mar 2021
13F
EVENTIDE ASSET MANAGEMENT, LLC
13F
Company
0.77%
500,000
$14,030,000 31 Mar 2021
13F
Avidity Partners Management LP
13F
Company
0.61%
400,000
$11,192,000 31 Mar 2021
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.35%
230,900
$6,479,000 31 Mar 2021
13F
FARALLON CAPITAL MANAGEMENT LLC
13F
Company
0.31%
200,000
$5,612,000 31 Mar 2021
13F
CAAS CAPITAL MANAGEMENT LP
13F
Company
0.08%
50,000
$1,399,000 31 Mar 2021
13F
Novo Holdings A/S
13F
Company
0.08%
50,000
$1,399,000 31 Mar 2021
13F
Marshall Wace North America L.P.
13F
Company
0.06%
39,008
$1,095,000 31 Mar 2021
13F
BlackRock Finance, Inc.
13F
Company
0.05%
33,382
$934,000 31 Mar 2021
13F
PERCEPTIVE ADVISORS LLC
13F
Company
0.04%
27,000
$755,000 31 Mar 2021
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.04%
24,428
$683,000 31 Mar 2021
13F
Pinz Capital Management, LP
13F
Company
0.03%
22,650
$634,000 31 Mar 2021
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.03%
16,384
$459,000 31 Mar 2021
13F
Lombard Odier SCmA Compagnie
13F
Individual
0.02%
15,030
$422,000 31 Mar 2021
13F
Zimmer Partners, LP
13F
Company
0.02%
15,000
$420,000 31 Mar 2021
13F
JPMORGAN CHASE & CO
13F
Company
0.02%
13,874
$389,000 31 Mar 2021
13F
Ensign Peak Advisors, Inc
13F
Company
0.01%
5,000
$140,000 31 Mar 2021
13F
MORGAN STANLEY
13F
Company
0.01%
4,835
$135,000 31 Mar 2021
13F
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP
13F
Company
0.01%
3,500
$98,000 31 Mar 2021
13F
Rokos Capital Management LLP
13F
Company
0%
2,500
$68,000 31 Mar 2021
13F
BANK OF AMERICA CORP /DE/
13F
Company
0%
500
$14,000 31 Mar 2021
13F
ROYAL BANK OF CANADA
13F
Company
0%
116
$3,000 31 Mar 2021
13F
UBS Group AG
13F
Company
0%
32
$1,000 31 Mar 2021
13F

Institutional Holders of Pharvaris N.V. - Ordinary Shares, par value Euro 0.12 per share (PHVS) as of Q2 2021

As of 30 Jun 2021, Pharvaris N.V. - Ordinary Shares, par value Euro 0.12 per share (PHVS) was held by 28 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 21,995,815 shares. The largest 10 holders included Foresite Capital Management IV, LLC, FMR LLC, Bain Capital Life Sciences Investors, LLC, GENERAL ATLANTIC, L.P., VIKING GLOBAL INVESTORS LP, venBio Partners LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), VR Adviser, LLC, Cormorant Asset Management, LP, and PICTET ASSET MANAGEMENT LTD. This page lists 28 institutional shareholders reporting positions in this security for the Q2 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2021 vs Q1 2021 Across Filers

Q1 2021 holders
33
Q2 2021 holders
28
Holder diff
-5
Investor Q1 2021 Shares Q2 2021 Shares Share Diff Share Chg % Q1 2021 Value $ Q2 2021 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .